MedTrace Logo

Central Hemodynamics

NCT01837784 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2013-04-23

No results posted yet for this study

Summary

Guidelines recommend measuring end organ damage and in particular arterial stiffness in patients with hypertension. However, until now it was not possible to measure arterial stiffness with the use of simple methods. Recently, novel and innovative devices offering determination of arterial stiffness and central hemodynamics from simple and non-invasive arm cuff measurements have now become available. This study therefore evaluates the value of non-invasively measured arterial stiffness and central hemodynamics for guiding antihypertensive treatment in selected patient populations (i.e. elderly patients, patients with diabetes mellitus, patients with heart failure, and patients with resistant hypertension).

Conditions

Interventions

OTHER

Optimization of blood pressure according to guidelines

There is no specific recommendation for the intervention. The goal of the intervention is an optimization of blood pressure control. The intervention is at the discretion of the physician, but should adhere to guidelines. The intervention may therefore embrace measures such as drug prescriptions or lifestyle interventions.

Sponsors & Collaborators

  • Luzerner Kantonsspital

    lead OTHER

Principal Investigators

  • Paul Erne, MD · Luzerner Kantonsspital

  • Paul Erne, MD · Luzerner Kantonsspital

  • Andreas W Schoenenberger, MD · University hospital of Bern

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2016-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01837784 on ClinicalTrials.gov